DrugPatentWatch Database Preview
Profile for African Regional IP Organization (ARIPO) Patent: 2324
» See Plans and Pricing
US Patent Family Members and Approved Drugs for African Regional IP Organization (ARIPO) Patent: 2324
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 27, 2027 | Celgene | REVLIMID | lenalidomide |
Start Trial | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
Start Trial | Nov 24, 2024 | Celgene | REVLIMID | lenalidomide |
Start Trial | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
Start Trial | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
Start Trial | May 15, 2023 | Celgene | REVLIMID | lenalidomide |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |